Bayer AG (BAYNd)
FRA • Healthcare
April 7, 2026 at 09:21 UTC
About Bayer AG
Bayer AG is a life-science company that develops medicines and agricultural solutions and brings them to market under a single operating philosophy: rigorous science, reliable supply, and guidance that clinicians and growers can use in routine settings. Research feeds clinical and field programs, manufacturing turns validated methods into repeatable production, and local teams adapt access and stewardship to regional rules. The enterprise treats discovery and delivery as one chain, with safety and labeling woven into each step. Healthcare units focus on therapies used in everyday practice, while crop-related units support resilience on farms and in supply networks. Across regions, the aim is to make complex innovation feel workable: instructions that fit the day, inventories that show up, and data that closes the loop between use and improvement. In the healthcare and materials ecosystem, Bayer acts as a long-horizon partner to systems that cannot pause.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Bayer AG's Technical Indicators Summary
BAYNd’s profile is bullish overall with price sitting above the short-term averages and well above the long-term EMA, suggesting longer-term support, while the 50-day measures offer some near-term resistance. Momentum indicators are mixed and ADX signals a moderate, not emphatic, trend, and ATR indicates moderate volatility. Volume on-balance is positive and both classic and Fibonacci pivots sit below the market, adding a mild constructive bias. Technical takeaway: Bullish—short-term strength and long-term support outweigh intermediate resistance, but the trend lacks strong conviction.
| Indicator | Value |
|---|---|
RSI (14) | 49.95 |
Stochastic %K (14, 3, 3) | 58.49 |
CCI (20) | 77.53 |
WPR (14) | -22.47 |
Momentum (10) | -0.50 |
MFI | 51.47 |
MACD Level (12, 26) | -0.76 |
Bollinger Bands | $36.61 - $40.68 |
ATR (14) | $1.46 (3.69%) |
ADX (14) | 22.90 |
OBV | 85,923,947 |
Classic Pivot Point | $38.72 |
Fibonacci Pivot Point | $38.72 |
Simple Moving Averages | $38.60 - $42.17(5 indicators) |
Exponential Moving Averages | $33.79 - $39.95(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
BAYNd finished the last trading session with a tiny decline, closing -1.06% beneath the prior close of 40.12. BAYNd eased modestly as a cautious market backdrop weighed on risk assets.
Price Change
from €39.7 close
+€0.5
Trading Volume
Below avg (2.5M)
1.8M
vs S&P 500 Today
Underperforming Market
-0.86%
52-Week Position
Upper range
66.9%
Updated: April 7, 2026 at 07:02 UTC
Quote Summary
BAYNd Headlines
Biotech, Pharma Stocks Draw Fresh Valuation Focus
April 2, 2026
Moderna, Mexico sign mRNA vaccine pact
February 11, 2026